Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangjing Xu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Science|January 10, 2018
Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patientsBingyu Yang, Chang Wang, Yiyu Xie, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple MyelomaJinge Xu, Bin Liu, Shoubao Ma, et al.
Biomed Research International|April 15, 2021
CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell LymphomaJie Cheng, Guanghua Chen, Hui Lv, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Science|January 10, 2018
Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patientsBingyu Yang, Chang Wang, Yiyu Xie, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple MyelomaJinge Xu, Bin Liu, Shoubao Ma, et al.
Biomed Research International|April 15, 2021
CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell LymphomaJie Cheng, Guanghua Chen, Hui Lv, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
Pageof 1